Clinical Study Results Sanofi Pharma, including Sanofi Genzyme

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter A

GENERIC NAME	TRADE NAME	CONDITION	STUDY CODE	STUDY NAME	ACCESS TO STUDY / PROTOCOL	ACCESS TO RESULTS
AAV2-SFLT01	Not Marketed	Age-Related Macular Degeneration	MSC12870	NA	NCT01024998	Publication's Reference
ABCA4 GENE THERAPY	Not Marketed	Stargardt's Disease	TDU13583	NA	EudraCT: 2010-023111-34	Tabulated Results
AFLIBERCEPT	Zaltrap	Cancer	TES10897	QUTIE	EudraCT: 2008-006796-80	Summary
AFLIBERCEPT	Zaltrap	Cancer	ARD6122	NA	NCT00327171	Tabulated Results
AFLIBERCEPT	Zaltrap	Cancer	ARD6123	NA	NCT00284141	Tabulated Results
AFLIBERCEPT	Zaltrap	Cancer	EFC6125	NA	NCT00327444	Tabulated Results
AFLIBERCEPT	Zaltrap	Cancer	EFC6546	NA	NCT00519285	Tabulated Results
AFLIBERCEPT	Zaltrap	Cancer	ARD6772	NA	NCT00396591	Tabulated Results
AFLIBERCEPT	Zaltrap	Cancer	EFC10262	VELOUR	NCT00561470	Tabulated Results
AFLIBERCEPT	Zaltrap	Cancer	EFC10261	VITAL	NCT00532155	Tabulated Results
AFLIBERCEPT	Zaltrap	Cancer	EFC10547	VANILLA	NCT00574275	Tabulated Results
AFLIBERCEPT	Zaltrap	Cancer	EFC10668	AFFIRM	NCT00851084	Tabulated Results
AFLIBERCEPT	Zaltrap	Cancer	EFC10668	AFFIRM	NCT00851084	Tabulated Results
AFLIBERCEPT	Zaltrap	Cancer	TCD11382	NA	NCT01148615	Summary
AFLIBERCEPT	Zaltrap	Cancer	TCD11470	NA	NCT01930552	Summary
AFLIBERCEPT	Zaltrap	Colorectal cancer	AFLIBC06561	AMOR	NCT01955629	Summary
AFLIBERCEPT	Zaltrap	Cancer	TCD6117	NA	NA	Summary
AFLIBERCEPT	Zaltrap	Colorectal cancer	EFC11338	AFLAME	NCT01661270	Tabulated Results
AFLIBERCEPT	Zaltrap	Colorectal cancer	EFC11885	NA	NCT01882868	Tabulated Results
AFLIBERCEPT	Zaltrap	Non Hodgkins Lymphoma	TCD10173	NA	NCT00644124	Summary
AFLIBERCEPT	Zaltrap	Colorectal cancer	AFLIBL06266	AFEQT	NCT01670721	Tabulated Results
AFLIBERCEPT	Zaltrap	Colorectal cancer	AFLIBC06097	NA	EudraCT: 2011-005724-17	Tabulated Results
AGALSIDASE BETA	Fabrazyme	Fabry Disease	AGAL-005-99	NA	NCT00074971	Publication's reference
AGALSIDASE BETA	Fabrazyme	Fabry Disease	AGAL-006-99*	NA		Summary
AGALSIDASE BETA	Fabrazyme	Fabry Disease	AGAL-007-99*	NA		Summary
AGALSIDASE BETA	Fabrazyme	Fabry Disease	AGAL-008-00	NA	NCT00074984	Tabulated Results
AGALSIDASE BETA	Fabrazyme	Fabry Disease	AGAL-016-01	NA	NCT00074958	Tabulated Results
AGALSIDASE BETA	Fabrazyme	Fabry Disease	AGAL-017-01	NA	NCT00196716	Tabulated Results
AGALSIDASE BETA	Fabrazyme	Fabry Disease	AGAL-019-01*	NA		Summary
AGALSIDASE BETA	Fabrazyme	Fabry Disease	AGAL-022-02	NA	NCT00837824	Tabulated Results
AGALSIDASE BETA	Fabrazyme	Fabry Disease	AGAL02503	NA	NCT00081497	Tabulated Results
AGALSIDASE BETA	Fabrazyme	Fabry Disease	AGAL06207	FIELD	NCT00701415	Tabulated Results
AGALSIDASE BETA	Fabrazyme	Fabry Disease	AGAL03204	NA	NCT00140621	Tabulated Results
AGALSIDASE BETA	Fabrazyme	Fabry Disease	AGAL-1-002-98*	NA		Summary
AGALSIDASE BETA	Fabrazyme	Fabry Disease	AGAL19110	NA	EudraCT: 2012-001966-14	Tabulated Results
AGALSIDASE BETA	Fabrazyme	Fabry Disease	AGAL19412	NA	NCT01650779	Tabulated Results
AGALSIDASE BETA	Fabrazyme	Fabry Disease	DIREGC07006	NA	NCT00196742	Publication Reference
AGALSIDASE BETA	Fabrazyme	Fabry Disease	FB9702-01*	NA		Summary
ALEMTUZUMAB	Campath	Leukemia	CAM203	NA	NCT00328198	Tabulated Results
ALEMTUZUMAB	Campath	Leukemia	CAM211*	NA		Summary
ALEMTUZUMAB	Campath	Leukemia	CAM307*	NA	NCT00046683	Summary
ALEMTUZUMAB	Campath	Leukemia	CAM314	NA	NCT00086580	Tabulated Results
ALEMTUZUMAB	Lemtrada	Multiple Sclerosis	ALEMLL08091	LemCourse	EudraCT: 2016-000464-42	Tabulated Results
ALEMTUZUMAB	Lemtrada	Multiple Sclerosis	ASY15905	LEMTRADA-ITP	NCT03784898	Tabulated Results
ALEMTUZUMAB	Lemtrada	Multiple Sclerosis	CAMMS223	NA	NCT00050778	Tabulated Results
ALEMTUZUMAB	Lemtrada	Multiple Sclerosis	CAMMS323	CARE-MS I	NCT00530348	Tabulated Results
ALEMTUZUMAB	Lemtrada	Multiple Sclerosis	CAMMS32400507	CARE-MS II	NCT00548405	Tabulated Results
ALEMTUZUMAB	Lemtrada	Multiple Sclerosis	CAMMS03409	CARE-MS II	NCT00548405	Tabulated Results
ALEMTUZUMAB	Lemtrada	Multiple Sclerosis	LPS13649	TOPAZ	NCT02255656	Tabulated Results
ALEMTUZUMAB	Lemtrada	Multiple Sclerosis	LPS13650	EMERALD	EudraCT: 2014-000092-62	Tabulated Results
ALEMTUZUMAB	Lemtrada	Multiple Sclerosis	TDU14260	SCALA	NCT02583594	Summary
ALEMTUZUMAB	Not Marketed	Multiple Sclerosis	TDU13475	NA	NCT02282826	Summary
ALEMTUZUMAB	Not Marketed	Multiple Sclerosis	TDU14981	NA	NCT02977533	Summary
ALEMTUZUMAB	Lemtrada	Multiple Sclerosis	OBS13436	NA	NCT03774914	Abstract
ALFUZOSIN	Uroxatral, Xatral	Prostatic Diseases	ALFUS_L_01241	SAMBA_THAILAND	NCT00401661	Summary
ALFUZOSIN	Uroxatral, Xatral	Prostatic Diseases	ALFUS_L_01667	SAMBA	NCT00486785	Summary
ALFUZOSIN	Uroxatral, Xatral	Benign Prostatic Hyperplasia	DRI5234	NA	NCT00409357	Summary
ALFUZOSIN	Uroxatral, Xatral	Benign Prostatic Hyperplasia	EFC4428	ALFAURUS	NCT00290030	Summary
ALFUZOSIN	Uroxatral, Xatral	Benign Prostatic Hyperplasia	EFC4485	NA	NCT00029822	Publication's reference
ALFUZOSIN	Uroxatral, Xatral	Neurogenic Urinary Bladder	EFC5722	ALPHACHIN	NCT00549939	Tabulated Results
ALFUZOSIN	Uroxatral, Xatral	Benign Prostatic Hyperplasia	EFC5791	NA	NCT00399464	Summary
ALFUZOSIN	Uroxatral, Xatral	Hydronephosis Neurogenic Bladder	EFC6269	ALPHAHYDRO	NCT00576823	Tabulated Results
ALFUZOSIN	Uroxatral, Xatral	Prostatic Diseases	L_8472	ALF-ACUTE	NCT00540891	Summary
ALFUZOSIN	Uroxatral, Xatral	Prostatic Diseases	L_8758	NA	NCT00637715	Summary
ALFUZOSIN	Uroxatral, Xatral	Prostatic Diseases	L_8819	NA	NCT00542165	Summary
ALFUZOSIN	Uroxatral, Xatral	Prostatic Diseases	L_8935	ALEX-XL	NCT00575913	Summary
ALFUZOSIN	Uroxatral, Xatral	Urologic Diseases	L_9397	ALF-RIK	NCT00453908	Summary
ALFUZOSIN	Uroxatral, Xatral	Prostatic Diseases	L_9645	NA	NCT00336921	Summary
ALFUZOSIN	Uroxatral, Xatral	Calculi	L_9795	ALF-STONE	EudraCT: 2005-005481-36	Summary
ALFUZOSIN	Uroxatral, Xatral	Benign Prostatic Hyperplasia	LTS5235	NA	NCT00347061	Summary
ALFUZOSIN	Uroxatral, Xatral	Urinary Bladder Neurogenic	PKM6270	ALPHACHIP	NCT00629720	Summary
ALFUZOSIN	Uroxatral, Xatral	Prostatic Diseases	PM_L_0168	ALFONE CHINA	NCT00280605	Summary
ALGLUCOSIDASE ALFA	Lumizyme	Pompe Disease Glycogen Storage Disease Type II (GSD II)	MSC12790/ AGLU07710	PAPAYA	2010-022231-11	Tabulated Results
ALGLUCOSIDASE ALFA	Myozyme	Pompe Disease	AGLU01602	NA	NCT00059280	Publication's Reference
ALGLUCOSIDASE ALFA	Myozyme	Pompe Disease	AGLU01702	NA	EudraCT: 2004-002168-59	Summary
ALGLUCOSIDASE ALFA	Myozyme	Pompe Disease	AGLU02704	NA	NCT00158600	Tabulated Results
ALGLUCOSIDASE ALFA	Myozyme	Pompe Disease	AGLU02804	NA	EudraCT: 2005-002829-31	Summary
ALGLUCOSIDASE ALFA	Myozyme	Pompe Disease	AGLU03206	NA	NCT00455195	Tabulated Results
ALGLUCOSIDASE ALFA	Myozyme	Pompe Disease	AGLU03306	NA	NCT00483379	Tabulated Results
ALGLUCOSIDASE ALFA	Myozyme	Pompe Disease	AGLU03707_MSC12817	NA	EudraCT: 2015-000583-34	Tabulated Results
ALGLUCOSIDASE ALFA	Myozyme	Pompe Disease	AGLU03807	NA	NCT00701129	Tabulated Results
ALGLUCOSIDASE ALFA	Myozyme	Pompe Disease	AGLU07310	NA	NCT01288027	Tabulated Results
ALGLUCOSIDASE ALFA	Myozyme	Pompe Disease	AGLU07510	NA	NCT01597596	Tabulated Results
ALGLUCOSIDASE ALFA	Myozyme	Pompe Disease	AGLU09411	NA	NCT01526785	Tabulated Results
ALGLUCOSIDASE ALFA	Myozyme	Pompe Disease	ALGMYL08718	APOLLO-IOPD	EudraCT: 2021-004047-25	Tabulated Results
ALGLUCOSIDASE ALFA	Myozyme® Lumizyme®	Pompe Disease; Glycogen Storage Disease Type II (GSD II); Acid Maltase Deficiency Disease	LTS12869	NA	NCT00486889	Tabulated Results
ALGLUCOSIDASE ALFA	Myozyme®/Lumizyme®	Pompe Disease	AGLU06909/LTS13930	NA	NCT01710813	Abstract
ALIROCUMAB	Praluent	Acute Coronary Syndrome	ALIROL08069	ODYSSEY J-IVUS	NCT02984982	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	DFI11565	NA	NCT01288443	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	DFI11566	NA	NCT01288469	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	DFI12361	NA	NCT01812707	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	DFI14223	ODYSSEY KIDS	EudraCT: 2015-003766-85	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	EFC14074	NA	NCT02289963	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	EFC11568	ODYSSEY COMBO I	NCT01644175	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	EFC11569	ODYSSEY COMBO II	NCT01644188	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	EFC11716	ODYSSEY MONO	NCT01644474	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	EFC12492	ODYSSEY FH I	NCT01623115	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	EFC12732	ODYSSEY HIGH FH	NCT01617655	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	EFC13672	ODYSSEY JAPAN	NCT02107898	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	EFC13786	ODYSSEY CHOICE II	NCT02023879	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	EFC13889	ODYSSEY EAST	NCT02715726	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	EFC14305	ODYSSEY-NIPPON	NCT02584504	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	EFC14660	NA	NCT03510715	Résultats compilés
ALIROCUMAB	Praluent	Dyslipidemia	LPS14354	ODYSSEY DM-Dyslipidemia	NCT02642159	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	LPS14245	ODYSSEY APPRISE	NCT02476006	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	LPS14355	ODYSSEY DM-Insulin	NCT02585778	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	LTS11717	ODYSSEY LONG TERM	NCT01507831	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	LTS13463	ODYSSEY OLE	EudraCT: 2013-002572-40	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	MSC14864	NA	NCT03415178	Tabulated Results
ALIROCUMAB	Praluent	Hypercholesterolemia	POP12671	NA	NCT01670734	Summary
ALIROCUMAB	Praluent	Cardiovascular Diseases	EFC11570	NA	NCT01663402	Tabulated Results
AMBROXOL	Not marketed	Acute Pharyngitis	LPS15328	DELICIOUS	NCT03583658	Summary
Amcenestrant	Not marketed	Breast Cancer	ACT16106	AMEERA-4	NCT04191382	Tabulated Results
AMIBEGRON	Not marketed	Major Depressive Disorder	EFC4846	ZEPHIR	NCT00319709	Summary
AMIBEGRON	Not marketed	Major Depressive Disorder	EFC5041	ORION	NCT00252356	Summary
AMIBEGRON	Not marketed	Major Depressive Disorder	EFC5116	PHOENIX	NCT00252330	Summary
AMIBEGRON	Not marketed	Major Depressive Disorder	EFC5374	NA	NCT00825058	Summary
AMIBEGRON	Not marketed	Major Depressive Disorder	EFC5379	NA	NCT00825019	Summary
AMIBEGRON	Not marketed	Generalized anxiety disorder	EFC5891	ELECTRA	EudraCT: 2005-003180-23	Summary
AMIBEGRON	Not marketed	Generalized anxiety disorder	EFC5892	LIBRA	NCT00252343	Summary
AMIBEGRON	Not marketed	Generalized anxiety disorder	EFC5893	AQUARIUS	EudraCT: 2005-003181-41	Summary
AMIBEGRON	Not marketed	Generalized anxiety disorder	EFC5895	GEMINI	EudraCT: 2006-004147-33	Summary Results
AMIBEGRON	Not marketed	Major Depressive Disorder	EFC6224	ALBERIO	EudraCT: 2006-004146-16	Summary Results
AMIBEGRON	Not marketed	Major Depressive Disorder	EFC6607	SIRIUS	NCT00385307	Summary
AMIBEGRON	Not marketed	Major Depressive Disorder	LTE5376	CALYPSO	EudraCT: 2005-004006-81	Summary Results
AMIBEGRON	Not marketed	Generalized anxiety disorder	LTE5894	VEGA	EudraCT: 2006-002253-71	Summary Results
AMIBEGRON	Not marketed	Major Depressive Disorder	LTS4848	NA	EudraCT: 2005-000577-21	Summary Results
AMISULPRIDE	Solian	Schizophrenia	AMISU_L_01008	AMIMIND	EudraCT: 2007-005772-13	Summary Results
AMISULPRIDE	Solian	Bipolar Disorder	C_8428	SOLMANIA	NCT00126009	Summary
AMISULPRIDE	Solian	Schizophrenia	L_8967	AMIRISMIND	NA	Summary
AMISULPRIDE	Solian	Schizophrenia	L_8968	NA	NCT00331981	Summary
AMISULPRIDE	Solian	Schizophrenia	L_9517	ASAP	NCT00436371	Summary
AMISULPRIDE	Solian	Schizophrenia	PM_L_0055	SOLIACS	EudraCT: 2004-004461-15	Summary Results
AMISULPRIDE	Solian	Schizophrenia	AMISUL06155	ESCAPE	NCT01795183	Summary
AMLITELIMAB	Not marketed	Atopic Dermatitis	ACT17369	NA	EudraCT: 2018-002299-41	Tabulated Results
ANTIBODY DRUG CONJUGATE	Not Marketed	Neoplasm Malignant	TED14147	NA	NCT02575781	Summary
ANTIBODY-DRUG CONJUGATE TARGETING SIALOGLYCOTOPE CA6/HUDS6	Not Marketed	Triple Negative Breast Cancer	TED10499	NA	NCT01156870	Summary
ANTI-CXCR5 MAB	Not Marketed	Systemic Lupus Erythematosus	TDR11407	NA	NCT02321709	Summary
ANTI-PNAG MONOCLONAL ANTIBODY	Not marketed	Infection prophylaxis	PKD11791	NA	NCT01389700	Summary
ANTI-THYMOCYTE GLOBULIN (RABBIT)	Thymoglobulin	kidney transplant rejection	SANG-93-3-K-THY-R*	NA		Summary
ANTI-THYMOCYTE GLOBULIN (RABBIT)	Thymoglobulin	kidney transplant rejection	SANG-96-3-K-THY-I*	NA		Summary
ANTI-THYMOCYTE GLOBULIN (RABBIT)	Thymoglobulin	kidney transplant rejection	SMC-101-1002*	NA		Summary
ANTI-THYMOCYTE GLOBULIN (RABBIT)	Thymoglobulin	kidney transplant rejection	SMC-101-1007*	NA		Summary
ANTI-THYMOCYTE GLOBULIN (RABBIT)	Thymoglobulin	kidney transplant rejection	SMC-101-1008*	NA		Summary
ANTI-THYMOCYTE GLOBULIN (RABBIT)	Thymoglobulin	kidney transplant rejection	SMC-101-1009*	NA		Summary
ANTI-THYMOCYTE GLOBULIN (RABBIT)	Thymoglobulin	kidney transplant rejection	SMC-534-1003*	NA		Summary
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN	Eloctate	Hemophilia A	EFC16225 (997HA306)	NA	NCT02234323	Summary
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN	Eloctate	Hemophilia A	LPS16473	verITI-8 Study	NCT03093480	Tabulated Results
Alogliptin	Nesina	Diabetes Mellitus, Type 2	ALOGLC08867	ACADEMIC	NCT03794336	Publication reference
ARTESUNATE	Arsucam	Malaria	ARTEN_L_00848	ACT MALI	NCT00452907	Summary
ARTESUNATE	Arsucam	Malaria	PM_L_0163	ATOL	NCT00445796	Summary
ARTESUNATE + AMODIAQUINE	Coarsucam	Malaria	ARAMF_L_01570	NA	NCT00386503	Summary
ARTESUNATE + AMODIAQUINE	Coarsucam	Malaria	ARAMF_L_02873	NA	NCT00540410	Summary
ARTESUNATE + AMODIAQUINE	Coarsucam	Malaria	PM_L_0164	ATAQ EASY	NCT00316329	Summary
ARTESUNATE + AMODIAQUINE	Coarsucam	Malaria	ARAMF_L_02661	NA	NCT00699920	Summary
ARTESUNATE + AMODIAQUINE	Coarsucam	Malaria	ARAMF_C_05370	NA	NCT01378286	Summary
ARTESUNATE + AMODIAQUINE	Coarsucam	Malaria	ARAMF_L_04314	NA	NCT01023399	Summary
ATACIGUAT	Not marketed	Pain, Neuropathic	DFI10569	SERENEATI	EudraCT: 2008-001518-26	Summary Results
ATACIGUAT	Not marketed	Peripheral Arterial Disease	DFI6174	ACCELA	NCT00443287	Summary
ATORVASTATIN/IRBESARTAN	Rovelito	Diabetes Mellitus, Type 2	ATOIRL07827	NA	NCT02842359	Summary
AVANAFIL	Spedra	Erectile Dysfuntion	AVANAL07163	CEDAR	NCT02503306	Summary

References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted